The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells

Drugs under Experimental and Clinical Research

Volumn 22, Issue 2, 1996, Pages 41-50

  Legallicier, B ^a,b   Leclere, C ^a   Monteil, C ^a   Elkaz, V ^a   Morin, J P ^a   Fillastre, J P ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; GLUTATHIONE; OXALIPLATIN; PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DNA SYNTHESIS; EPITHELIUM CELL; GLUCOSE TRANSPORT; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; OPOSSUM; PROTEIN SYNTHESIS; RABBIT; SPECIES DIFFERENCE; SWINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; KIDNEY TUBULES, PROXIMAL; OPOSSUMS; ORGANOPLATINUM COMPOUNDS; RABBITS; SWINE;

EID: 0029814651     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fillastre J.P., Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol. Lett., 46, 163, 1989.
2. Basinger M.A., Jones M.M., Holscher M.A. L-methionine antagonism of cis-platinum nephrotoxicity. Toxicol. Appl. Pharmacol., 103, 1, 1990.
3. Brady H.R., Kone B.C., Stromsk M.E., Zeidel M.L., Giebisch G., Gullans S.R. Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am. J. Physiol. 258, F1181, 1990.
4. Halabe A., Wong N.L.M., Sutton A.L. Effect of chronic cisplatin administration on phosphate and glucose transport by the renal brush border membrane. Nephron, 57, 197, 1991.
5. Mistry P., Merazga Y., Spargo D.J., Riley P.A., McBrien C.H. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother. Pharmacol., 28, 277, 1991.
6. Hu M.L., Tappel A.L. Glutathione and antioxidants protect microsomes against lipid peroxidation and enzyme inactivation. Lipids, 27, 42, 1992.
7. Weiss R.B., Christian M.C. New cisplatin analogues in development. A review. Drugs, 46, 360, 1993.
8. Kidani Y., Inagaki K. Antitumor activity of 1.2-diaminocyclohexane-platinum complexes against sarcoma-180 ascites form. J. Med. Chem., 21, 1315, 1978.
9. Extra J.M., Espie M., Calvo F., Ferme C., Mignot L., Marty M. Phase I study of oxaliplatin in patients which advanced cancer. Cancer Chemother. Pharmacol., 25, 299, 1990.
10. Kidani Y. Oxaliplatin. Drugs of the Future, 14, 529, 1989.
11. Levi F. et al. Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur. J. Cancer, 29A, 1280, 1993.
12. Toutain H., Vauclin-Jacques N., Fillastre J.P., Morin J.P. Biochemical, functional and morphological characterization of a primary culture of rabbit proximal tubule cells. Exp. Cell. Res., 194, 9, 1991.
13. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein, utilizing the principle of protein dye binding. Anal. Biochem., 72, 248, 1976.
14. Hjelle J.T., Morin J.P., Trouet A. Analytical cell fractionation of isolated rabbit renal proximal tubules. Kidney Int., 20, 71, 1981.
15. Pennington R.J. Biochemistry of dystrophic muscle mitochondrial succinate tetrazolium reductase and adenosine triphosphatase. Biochem. J., 80, 649, 1961.
16. Habig W.A., Pabst M.J., Jakoby W.B. GSH transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130, 1974.
17. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J Biochem. Physiol., 37, 911, 1959.
18. Kosugi H., Kikugawa K. Thiobarbituric acid reaction of aldehydes and oxidized lipids in glacial acetic acid. Lipids, 20, 915, 1985.
19. Okawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351, 1979.
20. Morin J.P., Monteil C., Leclere C., Elkaz V., Fillastre J.P. Phenotypic characterization of five culture models of renal proximal tubule cells: a rationale for selecting in vitro nephrotoxicity tests. Eur. Med. Res., 174, 1996.
21. Monteil C., Leclere C., Fillastre J.P., Morin J.P. Insulin and glucose impact on functional and morphological differentiation of rabbit proximal tubule cells in primary culture. Renal Physiol. Biochem., 16, 212, 1993.
22. Courjault F., Leroy D., Coquery I., Toutain H. Platinum complex-induced dysfunctions for cultured renal proximal tubule cells. Arch. Toxicol., 67, 338, 1993.
23. Monteil C., Leclere C., Fillastre J.P., Morin J.P. Characterization of gentamicin-induced dysfunction in vitro: the use of optimized primary cultures of rabbit proximal tubule cells. Ren. Fail., 15, 475, 1993.
24. Tay L.K., Bregman L., Masters B.A., Williams P.D. Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res., 48, 2538, 1988.
25. Uozomi J., Litterst C.L. The effect of cisplatin on renal ATPases in vivo and in vitro. Cancer Chemother. Pharmacol., 15, 93, 1985.
26. Boogaard P.J., Zoeteweij P., Van Berkel T.J.C., Van Noordende J.M., Mulder G.J., Nagelkerke J.F. Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity. Biochem. Pharmacol., 39, 1335-1345.
27. Bompart G., Orfila C. Cisplatin nephrotoxicity in lead-pretreated rats: enzymatic and morphological studies. Toxicol. Lett., 50, 237, 1990.
28. Bompart G., Orfila C., Manuel Y. Cisplatin nephrotoxicity in cadmium-pretreated rats. Enzymatic, functional and morphological studies. Nephron, 58, 60, 1991.
29. Nakano S., Gemba M. Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn. J. Pharmacol., 50, 87, 1989.
30. Sugihara K., Nakano S., Koda M., Tanaka K., Fukuishi N., Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn. J. Pharmacol., 43, 247, 1987.